American Journal of Nursing2022,Vol.122Issue(8) :2.DOI:10.1097/01.NAJ.0000854968.37305.7a

New Drug Treats Rare Genetic Overgrowth Disorder

Diane S.,Aschenbrenner
American Journal of Nursing2022,Vol.122Issue(8) :2.DOI:10.1097/01.NAJ.0000854968.37305.7a

New Drug Treats Rare Genetic Overgrowth Disorder

Diane S.,Aschenbrenner1
扫码查看

作者信息

  • 1. Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and
  • 折叠

Abstract

The Food and Drug Administration has approved alpelisib (Vijoice) to treat a rare noninherited genetic disorder called PIK3CA-related overgrowth spectrum.

引用本文复制引用

出版年

2022
American Journal of Nursing

American Journal of Nursing

SCI
ISSN:0002-936X
段落导航相关论文